-
1por Mohanty, Debasish, Dahlberg, Kevin, King, David M., David, Lamuel A., Sefat, Athena S., Wood, David L., Daniel, Claus, Dhar, Subhash, Mahajan, Vishal, Lee, Myongjai, Albano, Fabio“…Our results show that Al(2)O(3) coating improved the NMC cycling performance by 40% and the NCA cycling performance by 34% at 1 C/−1 C with respectively 4.35 V and 4.4 V UCV in 2 Ah pouch cells. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2por Allione, Attilio, Pivetta, Emanuele, Pizzolato, Elisa, Lorenzati, Bartolomeo, Pomero, Fulvio, Barutta, Letizia, Lauria, Giuseppe, Tartaglino, Bruno“…The presence of the caregiver would influence the rate of therapy administration [OR 6,19 (95% CI 2,6–14,75)]. The presence of leg pain [OR 0,32 (95% CI 0,12–0,86)] and head pain [OR 0,29 (95% CI 0,10–0,84)] were less likely associated to receive analgesia. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3“…The uncanny valley (UCV) hypothesis describes a non-linear relationship between perceived human-likeness and affective response. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4por Galloway, Sarah A. E., Dolton, Garry, Attaf, Meriem, Wall, Aaron, Fuller, Anna, Rius, Cristina, Bianchi, Valentina, Theaker, Sarah, Lloyd, Angharad, Caillaud, Marine E., Svane, Inge Marie, Donia, Marco, Cole, David K., Szomolay, Barbara, Rizkallah, Pierre, Sewell, Andrew K.“…Unfortunately, there is little opportunity to assess the effectiveness of individual T-cell clonotypes in vivo. Here, we identified effective, persistent T-cell clonotypes in an HLA A2(+) patient following successful tumour infiltrating lymphocyte (TIL) therapy. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5
-
6por Merino-Alado, Rommie, Pineda, Jacinto, Rasquin, Juan Hernandez, Landaeta, Maria Eugenia, Mata-Essayag, Sofía“…A 51 years old female patient with granulomatous mastitis diagnosis, was referred to the Medical Mycology Department “Dr. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
7por Szebeni, Gábor J., Alföldi, Róbert, Nagy, Lajos I., Neuperger, Patrícia, Gémes, Nikolett, Balog, József Á., Tiszlavicz, László, Puskás, László G.“…Interleukin-2 (IL-2) and oligonucleotide 2006 (ODN2006) adjuvants were used for the transfer of splenocytes from C57BL/6 mice into cyclophosphamide-treated BALB/c mice, resulting in prolonged survival, reduced tumor growth, and remission in 33% of the cases, without the development of the graft-versus-host disease. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8por Naranjo-Ruiz, Carmen, Martínez-Nova, Alfonso, Canel-Pérez, María de los Ángeles, López-Vigil, Miguel, Ferrer-Torregrosa, Javier, Barrios, Carlos“…Pre-surgery, the patients' scores were 42.82 ± 15.60. Scores improved at 6 months to 86.50 ± 8.6 and to 92.93 ± 8.6 at 12 months (p < 0.001 in both cases). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9por Mahmoudi, Tayebeh, Abdolmohammadi, Kamal, Bashiri, Hamed, Mohammadi, Mehdi, Rezaie, Mohammad Jafar, Fathi, Fardin, Fakhari, Shohreh, Rezaee, Mohammad Ali, Jalili, Ali, Rahmani, Mohammad Reza, Tayebi, Lobat“…Human umbilical cord vein-derived MSCs (hUCV-MSCs) were isolated and exposed to a sub-lethal concentration (15 μM for 24 h) of H(2) O(2) in vitro. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto